“At abcam, we put in an enormous amount of work into confirming the specificity of the antibodies,” Solache explains. The company uses knock-out cell lines to eliminate doubts about cross ...

The IWGAV recommended application testing and knock-out validation as key pillars for the validation of RUO antibodies 4, which Abcam has been doing for many years. The company has now raised the ...

Abcam - the global life sciences company was founded in 1998 by Jonathan Milner and David Cleevely to sell good-quality antibody reagents and is now a Nasdaq-listed multi-billion-dollar business ...